The PI3Kδ inhibitor idelalisib inhibits homing in an in vitro and in vivo model of B ALL

Etai Adam, Hye Na Kim, Eun Ji Gang, Caitlin Schnair, Solomon Lee, Solah Lee, Sajad Khazal, Osanna Kosoyan, Marina Konopleva, Chintan Parekh, Deepa Bhojwani, Alan S. Wayne, Hisham Abdel-Azim, Nora Heisterkamp, Yong Mi Kim

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number121
JournalCancers
Volume9
Issue number9
DOIs
StatePublished - Sep 10 2017
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • ALL
  • CAM-DR
  • Drug resistance
  • Idelalisib
  • Leukemia
  • Migration
  • Mouse model
  • PI3K

Cite this